Reuters logo
BRIEF-Sobi says wins approval from Health Canada for Orfadin for treatment of HT-1‍​
November 27, 2017 / 1:07 PM / 16 days ago

BRIEF-Sobi says wins approval from Health Canada for Orfadin for treatment of HT-1‍​

Nov 27 (Reuters) - Swedish Orphan Biovitrum:

* SAYS WINS APPROVAL FROM HEALTH CANADA FOR ORFADIN ORAL SUSPENSION FOR TREATMENT OF HT-1‍​ Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below